You need to enable JavaScript to run this app.
Recon: J&J’s lung cancer combo bests AstraZeneca’s Tagrisso in study; Galen robot gains clearance for ENT surgeries
Recon
Jason Scott
Global
ReconJason Scott
GlobalReconJason ScottGlobal